In Vivo is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


Atlas Genetics adds R&D expertise

This article was originally published in Clinica

Executive Summary

UK IVD firm Atlas Genetics has appointed Daniel Adlerstein director of research and development. Mr Adlerstein joins the Bath-based company from Diasorin, where he worked for over a decade and held various product development roles. These roles include building Diasorin’s molecular diagnostics program and developing molecular tests and instruments in infectious diseases and oncology. Mr Adlerstein’s knowledge in this area will come in handy in his new position at Atlas, which is developing ultra-rapid point-of-care tests for a range of infectious diseases.






Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts